Tonix Pharmaceuticals Holding Corp. (TNXP): Ernest Mario , director of Tonix Pharmaceuticals Holding Corp. purchased 100,000 shares on Sep 13, 2016. The Insider buying transaction was reported by the company on Sep 14, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.79 per share for a total value of $79,180.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 29, 2016, Samuel R Saks (director) purchased 12,500 shares at $2.00 per share price.On Jun 22, 2016, Seth Lederman (CEO) purchased 20,000 shares at $2.08 per share price.Also, On Jun 21, 2016, Bradley Saenger (CFO) purchased 2,000 shares at $2.00 per share price.On Jun 21, 2016, Ernest Mario (director) purchased 50,000 shares at $2.00 per share price.
Tonix Pharmaceuticals Holding Corp. (TNXP) witnessed a volatile trading activity on Monday Sep 12, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $0.7948 and reached the intraday high at $0.7948. The bulls started the profit booking and pushed the shares to intraday low of $0.75. The trading session was marked by a volume range of 822,010 shares exchanging hands. The 52-week high of the shares is $7.9541 and the 52-week low is $0.75. The market cap of the company stands at $20 M and there are 25,860,431 shares in public circulation.
Company has been under the radar of several Street Analysts.Tonix Pharmaceuticals Holding Corp. is Downgraded by ROTH Capital to Neutral. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Sep 7, 2016.